作者
Søren M Bentzen, Beste M Atasoy, Frances M Daley, Stanley Dische, Paul I Richman, Michele I Saunders, Klaus R Trott, George D Wilson
发表日期
2005/8/20
期刊
Journal of clinical oncology
卷号
23
期号
24
页码范围
5560-5567
出版商
American Society of Clinical Oncology
简介
Purpose
Accelerated repopulation is a main reason for locoregional failure after fractionated radiotherapy for head and neck squamous cell carcinoma (HNSCC). Epidermal growth factor receptor (EGFR) is a key controller of cellular proliferation in HNSCC, which stimulated the current study to look for a direct link between EGFR status and a possible clinical advantage of accelerated radiotherapy.
Patients and Methods
Immunohistochemical staining for EGFR was performed in 304 patients with available pretreatment tumor biopsy material among 918 patients randomized to receive continuous hyperfractionated accelerated radiotherapy versus conventionally fractionated radiotherapy. The EGFR index was estimated as the proportion of tumor cells with EGFR membrane staining.
Results
Significant benefit in locoregional tumor control from continuous hyperfractionated …
引用总数
2005200620072008200920102011201220132014201520162017201820192020202120222023202442332312322291919182418111410179342